20 June 2013
Keywords: britannia, airpharma, sign, accord, usa-based, uk, pharmaceuticals
Article | 15 November 2004
USA-based airPharma and the UK's Britannia Pharmaceuticals have signed a global licensing deal under which the former will develop AP0016, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 January 2005
24 May 2004
19 June 2013
© 2013 thepharmaletter.com